European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift

about

European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift

Item

http://www.wikidata.org/entity/Q58603898

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

European Association for the S ...... guidelines: The paradigm shift

@en

European Association for the S ...... guidelines: The paradigm shift

@nl

type

Item

label

European Association for the S ...... guidelines: The paradigm shift

@en

European Association for the S ...... guidelines: The paradigm shift

@nl

prefLabel

European Association for the S ...... guidelines: The paradigm shift

@en

European Association for the S ...... guidelines: The paradigm shift

@nl

P1476

European Association for the S ...... guidelines: The paradigm shift

@en

P2093

Marilyne Debette-Gratien

http://www.w3.org/2001/XMLSchema#string

Paul Carrier

http://www.w3.org/2001/XMLSchema#string

Véronique Loustaud-Ratti

http://www.w3.org/2001/XMLSchema#string

P2860

Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C

Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data.

Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.

Real world efficacy and safety of ombitasvir, Paritaprevir/r+Dasabuvir+Ribavirin IN genotype 1B patients with HCV liver cirrhosis.

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

Pilot Study: Combining Formal and Peer Education with FibroScan to Increase HCV Screening and Treatment in Persons who use Drugs.

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy.

P304

639-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4254/WJH.V10.I10.639

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386457

http://www.w3.org/2001/XMLSchema#string

P932

6206148

http://www.w3.org/2001/XMLSchema#string